CP 0494
Latest Information Update: 02 Jul 2002
At a glance
- Originator Cortech
- Class Analgesics
- Mechanism of Action Bradykinin B2 receptor antagonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 29 Feb 2000 Discontinued - Preclinical for Pain in USA (unspecified route)
- 02 Sep 1998 No-Development-Reported for Pain in USA (Unknown route)
- 17 Jul 1996 Preclinical development for Pain in USA (Unknown route)